Hercules Capital (STU:19H) Current Ratio

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

STU:19H Hercules Capital Inc STU:19H
61 GF Score
Price €14.06
GF Value €16.49
Valuation Modestly Undervalued
! 5 Warning Signs
View Full Analysis

What is Hercules Capital Current Ratio?

GuruFocus does not calculate Current Ratio for banks and insurance companies.

STU:19H
61GF Score
Hercules Capital Inc STU:19H
Current Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Hercules Capital (STU:19H) Overvalued in 2026?

Based on GuruFocus' analysis, Hercules Capital stock appears to be undervalued. The current stock price of €14.06 is trading 14.7% below its estimated GF Value™ of €16.49. GuruFocus considers Hercules Capital to be Modestly Undervalued.

Key valuation signals for STU:19H:

  • Current Ratio:
  • GF Value™: €16.49 vs. price of €14.06 (14.7% below fair value)
  • GF Score™: 61/100 with 5 warning signs

No single metric tells the full story. See the STU:19H stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Hercules Capital Business Description

Other Exchanges HTGC:USA0J4M:UK
Address 1 North B Street, Suite 2000, San Mateo, CA, USA, 94401
Hercules Capital Inc is a specialty finance company focused on providing senior secured loans to high-growth, venture capital-backed, and institutional-backed companies in a variety of technology and life sciences industries. The company's primary business objectives are to increase its net income, net investment income, and net asset value (NAV) through its investments mainly in structured debt or senior secured debt instruments of venture capital-backed and institutional-backed companies across a variety of technology-related industries at attractive yields. It finances companies belonging to computer software and hardware, networking systems, semiconductors, medical devices, bio-pharmaceutical, and other related sectors.
61GF Score

Get the complete analysis for STU:19H

Current Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€14.06
Price
€16.49
GF Value